FDA Commissioner Scott Gottlieb, MD, calls on social media sites and internet providers to crack down on illegal online opioid sales; Ohio will require pharmacy benefit managers and insurers to inform patients of the lowest price for a drug; a court is weighing if a hospital is responsible for a discharged patient with schizophrenia who committed murder.
FDA Commissioner Scott Gottlieb, MD, has called on social media sites and internet providers to help curb illegal sales of opioids. According to The Hill, he believes these entities could be doing more to find and put an end to these illegal sales on their platforms. The FDA wants to bring together CEOs and internet stakeholders to find gaps and solutions to reduce the availability of opioids online.
As part of a push to ensure insured consumers don’t end up paying more for a drug than those without insurance, the Ohio Department of Insurance is going to require insurers and pharmacy benefit managers to disclose the lowest price for a drug. The state will also ban the practice that prohibits pharmacists from discussing when low-cost options are available, reported Reuters. There are similar moves happening at the federal level with 2 bills—the Patient Right to Know Drug Prices Act and the Know the Lowest Price Act of 2018—aimed at preventing “gag clauses.”
Massachusetts’ highest court is weighing whether a hospital should be responsible for a former patient who committed a crime. The New York Times reported that a hospital had released a patient diagnosed with schizophrenia and court ordered to be held for up to 6 months after just 11 days at the hospital. Within weeks of his release, he had killed a neighbor. The plaintiffs’ attorneys allege that the patient was clearly still dangerous when he was discharged and that the hospital is at fault for violating the court order to release him early.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More